Baxter International Inc., Research & Development, Holger-Crafoord-Str. 26, 72379, Hechingen, Germany.
Sci Rep. 2019 May 1;9(1):6791. doi: 10.1038/s41598-019-43161-2.
Haemodialysis effectively removes small solutes and smaller-sized middle molecules from the blood; however, the clearance of larger middle molecules, which have been associated with negative effects, is poor. The novel medium cut-off (MCO) dialysis membrane has larger pore sizes and a more open structure than other high-flux membranes, providing improved removal of larger middle molecules while retaining albumin. However, larger pore sizes may potentially increase permeability to pyrogens, including endotoxins and other bacterial contaminants, that could be present in the dialysis fluid. In this study, we tested the capacity of low-flux, high-flux, MCO and high cut-off dialyser membranes with different pore sizes to prevent pyrogens crossing from dialysate to the blood side in a closed-loop test system, differentiating among lipopolysaccharides, peptidoglycans and bacterial DNA using a toll-like receptor assay. Even though the bacterial contamination levels in our test system exceeded the acceptable pyrogen dose for standard dialysis fluid, levels of lipopolysaccharides, peptidoglycans and bacterial DNA in the blood-side samples were too low to identify potential differences in pyrogen permeability among the membranes. Our results suggest that MCO membranes are suitable for haemodialysis using ISO standard dialysis fluid quality, and retain endotoxins at a similar level as other membranes.
血液透析能有效地从血液中清除小分子溶质和较小的中分子物质;然而,对于与负面效应相关的较大的中分子物质的清除效果较差。新型中分子截留(MCO)透析膜的孔径大于其他高通量膜,结构更开放,在保留白蛋白的同时,能更好地清除较大的中分子物质。然而,较大的孔径可能会增加对内毒素和其他细菌污染物等热原的通透性,这些污染物可能存在于透析液中。在这项研究中,我们使用封闭环路测试系统,用不同孔径的低通量、高通量、MCO 和高截留透析器膜测试了阻止热原从透析液侧转移到血液侧的能力,使用 toll 样受体检测法对脂多糖、肽聚糖和细菌 DNA 进行了区分。尽管我们的测试系统中的细菌污染水平超过了标准透析液的可接受热原剂量,但血液侧样本中的脂多糖、肽聚糖和细菌 DNA 水平太低,无法确定不同膜之间热原通透性的潜在差异。我们的研究结果表明,MCO 膜适用于使用 ISO 标准透析液质量的血液透析,并且与其他膜一样,能保持内毒素的水平相似。